Peringkat dalam Saham
#28557
PlexBio Co., Ltd. is dedicated to the creation and production of in vitro... PlexBio Co., Ltd. is dedicated to the creation and production of in vitro diagnostic (IVD) solutions for both molecular biology and immunology purposes. Their comprehensive product range features services for optimizing diagnostic workflows, as well as automated kits for sample preparation and extraction. A key innovation is their IntelliPlex platform, which leverages pCode technology to enable advanced, "sample-to-answer" multiplexing assays. The company also supplies specialized oncology panels designed for detecting lung cancer, gene mutations, and chromosomal rearrangements. Additionally, PlexBio offers a variety of infectious disease tests, including IntelliPlex kits for SARS-CoV-2 detection, influenza, and SARS-CoV-2 variant analysis, complemented by essential reagents such as pCode coupling buffer sets. Founded in 2009, PlexBio Co., Ltd. operates from its headquarters in Taipei, Taiwan.
Kapitalisasi Pasar
$25.81M
Perubahan (1 tahun)
-24.39%
Perdagangan PlexBio Co., Ltd. (6572)
Harga 6572 dengan kapitalisasi pasar B
Kapitalisasi pasar dari PlexBio Co., Ltd.(6572)
Kapitalisasi Pasar: $25.81M
Per August 2026, PlexBio Co., Ltd. memiliki kapitalisasi pasar sebesar $25.81M. Ini menjadikan PlexBio Co., Ltd. sebagai perusahaan 28557th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar PlexBio Co., Ltd. dari 2016 hingga 2026
6572 dibandingkan dengan 5 teratas stocks paling populer
| Harga 6572 |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.301T
|
+20,538,841.25%
|
|
|
|
|
$4.634T
|
+17,954,458.51%
|
|
|
|
|
$4.143T
|
+16,052,448.24%
|
|
|
|
|
$3.589T
|
+13,907,417.87%
|
|
|
|
|
$2.857T
|
+11,069,539.98%
|
